share_log

Truist Securities Maintains Buy on PROCEPT BioRobotics, Raises Price Target to $79

Truist Securities Maintains Buy on PROCEPT BioRobotics, Raises Price Target to $79

Truist Securities保持对PROCEPT BioRobotics的买入评级,将目标价格上调至79美元。
Benzinga ·  07/16 09:55

Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and raises the price target from $72 to $79.

Truist Securities分析师理查德·纽特维持ProCEPT BioRobotics(纳斯达克股票代码:PRCT)的买入并将目标股价从72美元上调至79美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发